CTI BioPharma

1 follower

‌

CTI BioPharma (NASDAQ: CTIC) is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers.

Industries

Biotechnology, Education

Headquarters

Seattle, United States

Employees

201-500

Links

Org chart

Adam R. Craig

President, CEO & Interim Chief Medical Officer

Adam R. Craig

Collapse

James K. Fong

SVP, Commercial Operations

William Born

Senior Director Strategic Pricing And Contracting

Mary Beth Lanza

Senior Director Learning And Development

Shah Nawaz Sulehria

Operations Manager Development Program

Wendy Wilson

Associate Director Medical Affairs

Tina Bush

Key Account Manager

Allison Hylton

Senior Corporate Controller/senior Director

Dawn Waldorf

Key Account Manager

Tom Rice

Account Manager

Teams

Sales and Account Management

12 members

Finance and Operations Team

4 members

Medical and Clinical Affairs

5 members

Leadership Team

1 members

Similar companies

Voyager Therapeutics

1 follower

Alector

3 followers

Vir Biotechnology

3 followers

Akebia Therapeutics

3 followers

Southern Poverty Law Center

3 followers

Arvinas

3 followers

BridgeBio

2 followers

23andMe

81 followers

TG Therapeutics

1 follower

AxoGen

1 follower

Watermark

1 follower

Explore companies